Welcome to Talking ADHD, an audio CME program for healthcare professionals working with and caring for patients with ADHD. In each quarterly CME-accredited issue, Robert L. Findling, MD, discusses a compelling area in ADHD with guest experts, and there are slides and links to relevant references available to help you find out more about the topic. Between the quarterly CME programs, we present biweekly In Discussion updates, featuring news, an interview, and brief commentary: Dr Findling discusses recent research in the field with the researchers involved to provide you with the latest intelligence on ADHD.

New! CME program transcripts are now available to facilitate the post-program CME testing!

High-dose atomoxetine treatment of ADHD
Dr. Atilla Turgay of The Scarborough Hospital, Toronto, discusses his studies on the use of atomoxetine, including using high doses in children who do not respond well to standard doses.
Is ADHD overdiagnosed?
Dr. Mark Sciutto of Muhlenberg College in Allentown, Pennsylvania, USA, describes his research to discover whether ADHD is overdiagnosed in America, as media reports suggest.
ADHD service use patterns in youth
Dr. Mark Wolraich, of the University of Oklahoma Health Sciences Center in Oklahoma City, Oklahoma, USA, reviews the treatment of ADHD, discussing who children visit for healthcare and what treatment they receive.
Brain morphology and ADHD
Dr. Steven Pliszka of the University of Texas Health Science Center, San Antonio, USA, tells us about his brain imaging studies which have looked at brain structure volumes in children with ADHD versus those without ADHD.
Health problems and quality of life in children with ADHD
Dr. Anne Riley of the Johns Hopkins University Bloomberg School of Public Health discusses how ADHD can affect children’s quality of life and how it compares to other chronic pediatric diseases.
Cognitive-behavioral approaches to ADHD treatment in adulthood
Dr. Steven Safren of Harvard Medical School and Massachusetts General Hospital tells us about his program of cognitive-behavioral approaches to the treatment of ADHD in adults.
ADHD in primary care
Dr. Alison Schonwald, Medical Director of Developmental Outreach of the Developmental Medicine Center at Children's Hospital, Boston, USA, reviews how ADHD is recognized and treated in the primary care office, and what help is available for primary care physicians.
ADHD and achievement
Dr. Thomas Frazier of the Cleveland Clinic Foundation discusses how ADHD can impact on achievement in children, adolescents and adults, and looks at how long the effects can last.
ADHD and comorbid anxiety
Dr. Anthony Rostain of the University of Pennsylvania discusses the etiology and effects of ADHD with comorbid anxiety.
The MTA Study
Dr. Eugene Arnold, Professor Emeritus of Psychiatry at Ohio State University, reviews the design and results of the ongoing Multimodal Treatment of Children with ADHD (MTA) study, discussing the updated findings soon to be published.
Cognitive effects of comorbidities
Susan Crawford of the Alberta Children's Hospital and the Institute of Maternal and Child Health at the University of Calgary talks about the increased impairment in functioning that is seen in children with ADHD and comorbid disorders.
Diagnosis: ADHD or a sleep disorder?
Dr J.J. Sandra Kooij of the Parnassia psycho-medical center in the Netherlands discusses the shared symptomatology and possibility of confusion between the diagnoses of hypersomnia and adult ADHD.
Suicidal thinking and ADHD medication
Dr Russell Barkley of SUNY Upstate Medical University will be talking about the recent Public Health Advisory issued by the FDA following reports of suicidal thinking in children and adolescents taking medication for ADHD.
Diversion of ADHD medication
Dr. Christian Teter of Northeastern University's Bouvé College of Health Sciences, Boston, USA, discusses the prevalence and factors associated with the illicit use of prescription stimulants among undergraduate college students, and his studies assessing the relationship between medical and illicit use of these drugs.
Genetics of ADHD
Dr. Philip Asherson of King's College, London, UK, talks about the genetic associations with ADHD and his research to identify novel genes.
Prevalence of ADHD worldwide
Dr. Stephen Faraone from SUNY Upstate Medical University, NY, USA, refutes the idea that ADHD is solely an American disorder by examining its international prevalence.
Substance use and ADHD
Dr. Gerald August, from the University of Minnesota Medical School, USA, discusses his research findings about late adolescent drug use in a large community sample of patients with ADHD.
Psychotropic drug use in children: an APA report
Dr. Ronald Brown of the College of Health Professions, Temple University, PA, USA, and chair of the American Psychological Association (APA) Working Group on Psychotropic Medications for Children and Adolescents tells us about the group’s recent report examining various drug treatments in children.
Neuroimaging and ADHD
Dr Eve Valera of Harvard Medical School and Massachusetts General Hospital, Boston, USA, tells us about her work on brain imaging in ADHD.
Parent vs teacher reports of ADHD
Dr Gregory Fabiano from the University at Buffalo Graduate School of Education, NY, USA, discusses with Dr Findling how reports of ADHD symptoms differ between parents and teachers.
ADHD stimulants and growth suppression
Dr Alice Charach from the Hospital for Sick Children and the University of Toronto, Canada, talks about her research on stimulants and growth suppression.
ADHD drugs and cardiovascular risk
Dr Steven Nissen of the Cleveland Clinic, Ohio, USA, shares his findings concerning the cardiovascular risk associated with ADHD stimulants.
The malignant effects of ADHD during childhood
Professor Janet Currie of Columbia University, NY, USA, discusses her research on the effects of ADHD on childhood outcomes.
Stimulants and tics
Dr Findling talks to Dr Gerald Erenberg of The Cleveland Clinic, Ohio, USA, about his research on first-onset tics in children taking stimulants for ADHD.

Program 1: A Transdermal Methylphenidate Delivery System

September 28th 2006
Featuring Dr Frank Lopez and Dr Sharon Wigal

Drs Frank Lopez and Sharon Wigal join Dr Findling to discuss the newly-launched methylphenidate transdermal delivery system, including its pros and cons, patient selection, safety issues, and much more.

Program 2: Adult ADHD

January 26th 2007
Featuring Dr Craig Surman and Dr Richard Weisler

Drs Surman and Weisler talk with Dr Findling about the challenges of recognizing and treating ADHD in adults.

Program 3: Preschool ADHD Treatment Study

May 4th 2007
Featuring Dr Jaswinder Ghuman and Dr Scott Kollins

Drs Ghuman and Kollins discuss the methodology, findings, and implications of the Preschool ADHD Treatment Study with Dr Findling.

Program 4: Long-term Treatment Issues in ADHD

August 31st 2007
Featuring Dr Larry Culpepper and Dr Raul Silva

Drs Culpepper and Silva discuss with Dr Findling the issues surrounding long-term pharmacological treatment of ADHD, including both the benefits and associated adverse effects.